K305-0104 Screening compound: 3-(4-ethoxyphenyl)-1-{[(2-ethoxyphenyl)carbamoyl]methyl}-N,N,5-trimethyl-2,4-dioxo-1H,2H,3H,4H-thieno[2,3-d]pyrimidine-6-carboxamide

K305-0104 Screening compound: 3-(4-ethoxyphenyl)-1-{[(2-ethoxyphenyl)carbamoyl]methyl}-N,N,5-trimethyl-2,4-dioxo-1H,2H,3H,4H-thieno[2,3-d]pyrimidine-6-carboxamide
K305-0104 Screening compound: 3-(4-ethoxyphenyl)-1-{[(2-ethoxyphenyl)carbamoyl]methyl}-N,N,5-trimethyl-2,4-dioxo-1H,2H,3H,4H-thieno[2,3-d]pyrimidine-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K305-0104
3-(4-ethoxyphenyl)-1-{[(2-ethoxyphenyl)carbamoyl]methyl}-N,N,5-trimethyl-2,4-dioxo-1H,2H,3H,4H-thieno[2,3-d]pyrimidine-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K305-0104

Molecular Formula

C28H30N4O6S (C28 H30 N4 O6 S)

Compound Name

3-(4-ethoxyphenyl)-1-{[(2-ethoxyphenyl)carbamoyl]methyl}-N,N,5-trimethyl-2,4-dioxo-1H,2H,3H,4H-thieno[2,3-d]pyrimidine-6-carboxamide

IUPAC name

3-(4-ethoxyphenyl)-1-{[(2-ethoxyphenyl)carbamoyl]methyl}-NN5-trimethyl-24-dioxo-1H2H3H4H-thieno[23-d]pyrimidine-6-carboxamide

SMILES

CCOc(cc1)ccc1N(C(c1c(N2CC(Nc(cccc3)c3OCC)=O)sc(C(N(C)C)=O)c1C)=O)C2=O

InChI

InChI=1S/C28H30N4O6S/c1-6-37-19-14-12-18(13-15-19)32-25(34)23-17(3)24(26(35)30(4)5)39-27(23)31(28(32)36)16-22(33)29-20-10-8-9-11-21(20)38-7-2/h8-15H,6-7,16H2,1-5H3,(H,29,33)

InChI Key

ZZNNHSPCYRKAJJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15092723

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

550.64

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.097

Distribution Coefficient, logD

3.097

Water Solubility, LogSw

-3.34

Polar Surface Area

83.893

Acid Dissociation Constant (pKa)

11.59

Base Dissociation Constant (pKb)

2.42

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

K305-0104 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with K305-0104 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K305-0104?
Check Price and Availability of K305-0104, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K305-0104 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K305-0104
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K305-0104
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K305-0104 available by request